New and emerging pharmacological targets for neuropathic pain
- PMID: 15115637
- DOI: 10.1007/s11916-004-0051-7
New and emerging pharmacological targets for neuropathic pain
Abstract
Increasing knowledge of the molecular consequences of nerve injury and the availability of genome databases has greatly increased the range of potential targets for the pharmacological management of neuropathic pain. Controlling neuronal sensitization and the associated alterations in gene expression, protein modification, and neuronal excitability is the key to managing neuropathic pain. Control of neuronal sensitization can occur through inhibition of nerve injury-associated production of cytokines, activation of glial cells, modulation of potassium channel subtypes, mitogen-activated protein kinases, the ubiquitin-proteasome system, or the protection and amplification of spinal cord dorsal horn inhibitory systems. These new and already established targets promise unparalleled opportunities for the prevention, management, and resolution of persistent pain states following nerve injury.
Similar articles
-
[Contribution of primary sensory neurons and spinal glial cells to pathomechanisms of neuropathic pain].Brain Nerve. 2008 May;60(5):483-92. Brain Nerve. 2008. PMID: 18516970 Review. Japanese.
-
Neuronal-Glial Interactions Maintain Chronic Neuropathic Pain after Spinal Cord Injury.Neural Plast. 2017;2017:2480689. doi: 10.1155/2017/2480689. Epub 2017 Aug 29. Neural Plast. 2017. PMID: 28951789 Free PMC article. Review.
-
Tanshinone IIA attenuates neuropathic pain via inhibiting glial activation and immune response.Pharmacol Biochem Behav. 2015 Jan;128:1-7. doi: 10.1016/j.pbb.2014.11.004. Epub 2014 Nov 6. Pharmacol Biochem Behav. 2015. PMID: 25449357
-
Neuropathic pain: mechanisms and treatments.Chang Gung Med J. 2005 Sep;28(9):597-605. Chang Gung Med J. 2005. PMID: 16323550 Review.
-
Importance of glial activation in neuropathic pain.Eur J Pharmacol. 2013 Sep 15;716(1-3):106-19. doi: 10.1016/j.ejphar.2013.01.072. Epub 2013 Mar 13. Eur J Pharmacol. 2013. PMID: 23500198 Review.
Cited by
-
Role of the Ubiquitin System in Chronic Pain.Front Mol Neurosci. 2021 May 28;14:674914. doi: 10.3389/fnmol.2021.674914. eCollection 2021. Front Mol Neurosci. 2021. PMID: 34122010 Free PMC article. Review.
-
Complex regional pain syndrome: what's in a name?J Pain. 2011 Jan;12(1):2-12. doi: 10.1016/j.jpain.2010.06.001. Epub 2010 Jul 15. J Pain. 2011. PMID: 20634146 Free PMC article.
-
Reciprocal regulation of nuclear factor kappa B and its inhibitor ZAS3 after peripheral nerve injury.BMC Neurosci. 2006 Jan 12;7:4. doi: 10.1186/1471-2202-7-4. BMC Neurosci. 2006. PMID: 16409637 Free PMC article.
-
Effects of curcumin on pain threshold and on the expression of nuclear factor κ B and CX3C receptor 1 after sciatic nerve chronic constrictive injury in rats.Chin J Integr Med. 2014 Nov;20(11):850-6. doi: 10.1007/s11655-013-1549-9. Epub 2014 Jan 28. Chin J Integr Med. 2014. PMID: 24474673
-
Targeting Microglial Immunoproteasome: A Novel Approach in Neuroinflammatory-Related Disorders.ACS Chem Neurosci. 2024 Jul 17;15(14):2532-2544. doi: 10.1021/acschemneuro.4c00099. Epub 2024 Jul 6. ACS Chem Neurosci. 2024. PMID: 38970802 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources